• Which of the following is true of clinical trials in GBM?

  • Which of the following is a best practice for treating patients with GBM?

  • Which of the following is true of the AVAglio clinical trial in newly diagnosed GBM patients?

  • Which of the following is most important to patients with GBM?

  • What are the most important factors associated with patient prognosis in GBM?

  • In addition to QoL concerns for patients with GBM, what are the other important considerations for these patients?

  • What is the standard of care for newly diagnosed patients?

  • Which of the following describes the current indication for the targeted agent bevacizumab in patients with GBM?

Upon making your choice, the next question will automatically appear. If you wish to choose a different answer/review your answer please use the “back” button.